Executive Director of SIRNAOMICS-B Increases Stake by 38,000 Shares

Stock News03-30

SIRNAOMICS-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the company's executive director and chairman, that Dr. Pan purchased a total of 38,000 ordinary shares in the open market on March 30, 2026, using personal funds at an average price of approximately HK$5.93 per share. Following the acquisition, Dr. Pan holds an interest in a total of 17,665,700 shares, representing 16.10% of the company's total issued share capital as of the date of this announcement. According to Dr. Pan, he has full confidence in the overall development prospects and potential growth of the group. Subject to applicable laws and regulatory requirements, Dr. Pan does not rule out the possibility of further increasing his stake in the company at an appropriate time.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128745765?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 23:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128745765","market":"us","top_or_hot":-1,"title":"Executive Director of SIRNAOMICS-B Increases Stake by 38,000 Shares","media":"Stock News","content":"<p>SIRNAOMICS-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the company's executive director and chairman, that Dr. Pan purchased a total of 38,000 ordinary shares in the open market on March 30, 2026, using personal funds at an average price of approximately HK$5.93 per share. Following the acquisition, Dr. Pan holds an interest in a total of 17,665,700 shares, representing 16.10% of the company's total issued share capital as of the date of this announcement. According to Dr. Pan, he has full confidence in the overall development prospects and potential growth of the group. Subject to applicable laws and regulatory requirements, Dr. Pan does not rule out the possibility of further increasing his stake in the company at an appropriate time.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Executive Director of SIRNAOMICS-B Increases Stake by 38,000 Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExecutive Director of SIRNAOMICS-B Increases Stake by 38,000 Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-30 23:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SIRNAOMICS-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the company's executive director and chairman, that Dr. Pan purchased a total of 38,000 ordinary shares in the open market on March 30, 2026, using personal funds at an average price of approximately HK$5.93 per share. Following the acquisition, Dr. Pan holds an interest in a total of 17,665,700 shares, representing 16.10% of the company's total issued share capital as of the date of this announcement. According to Dr. Pan, he has full confidence in the overall development prospects and potential growth of the group. Subject to applicable laws and regulatory requirements, Dr. Pan does not rule out the possibility of further increasing his stake in the company at an appropriate time.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02257","symbol_name":"圣诺医药-B","start_time":0,"source_url":"","article_id":"1128745765","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128745765","pubTimestamp":1774883944,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"SIRNAOMICS-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the company's executive director and chairman, that Dr. Pan purchased a total of 38,000 ordinary shares in...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02257":"圣诺医药-B","BK1161":"生物科技"},"translate_title":"圣诺生物-B执行董事增持3.8万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02257":1},"content_text":"SIRNAOMICS-B (02257) announced that the board of directors was informed by Dr. Pan Honghui, the company's executive director and chairman, that Dr. Pan purchased a total of 38,000 ordinary shares in the open market on March 30, 2026, using personal funds at an average price of approximately HK$5.93 per share. Following the acquisition, Dr. Pan holds an interest in a total of 17,665,700 shares, representing 16.10% of the company's total issued share capital as of the date of this announcement. According to Dr. Pan, he has full confidence in the overall development prospects and potential growth of the group. Subject to applicable laws and regulatory requirements, Dr. Pan does not rule out the possibility of further increasing his stake in the company at an appropriate time.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128745765","isCrawlerRequest":true}